Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects

A cell-based process may be better suited for vaccine production during a highly pathogenic avian influenza (HPAI) pandemic. This was a phase 3, randomized, controlled, observer-blind, multicenter study evaluated safety, immunogenicity, and lot-to-lot consistency of two doses of a MF59-adjuvanted, H...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, James, Van Twuijver, Esther, Versage, Eve, Hohenboken, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027673/
https://www.ncbi.nlm.nih.gov/pubmed/35455245
http://dx.doi.org/10.3390/vaccines10040497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027673/
https://www.ncbi.nlm.nih.gov/pubmed/35455245
http://dx.doi.org/10.3390/vaccines10040497

Ejemplares similares